TSHA Competitors & Alternatives
Compare Taysha Gene Therapies Inc with similar stocks in the same industry
Biotechnology
TSHA
Main Stock$5.38
Tradestie Score
51
Market Cap
$867.49M
Revenue Growth
1.7%
Analyst Upside
+141.6%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCUL
Ocular Therapeutix, Inc.
|
$9.88
|
$1.92B | - | 63 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$103.79
|
$1.92B | - | 58 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$71.21
|
$1.90B | 458.4 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$41.50
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.49
|
$1.81B | - | 62 | Compare |
|
MPLT
MPLT
|
$36.57
|
$1.78B | - | 63 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$6.52
|
$1.78B | - | 59 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$23.64
|
$1.78B | - | 63 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$18.99
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.53
|
$1.68B | - | 62 | Compare |
More TSHA Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry